Bhubaneswar (Odisha): Hyderabad-based Bharat Biotech International Ltd (BBIL) on Friday said it would manufacture 10 types of vaccines against COVID-19, malaria and other diseases in its upcoming unit in Odisha.
BBIL Chairman and Managing Director Dr Krishna Ella said this while attending a meeting through digital mode with Odisha chief secretary A K Tripathy and other state government officials.
BBIL is a multi-dimensional biotechnology organisation specializing in the manufacture of vaccines and biotherapeutics, Ella said.
The company has taken up the development and production of new or improved vaccines against severe Rotavirus Diarrhoea, Malaria, Japanese Encephalitis, Rabies, Pandemic Influenza and drug-resistant Staphylococcus aureus, he said.
In BBIL's unit at Andharua of Bhubaneswar, the company would produce 10 types of vaccines including malaria and COVID-19, he said, adding that the total investment would be around Rs 300 crore.
Best of the technology will be put in the Odisha unit, the BBIL chief said.
Also read:JNMC to conduct last-stage trials for Bharat Biotech's Covid-19 vaccine